Monday 20 April 2015

Immune Checkpoint Drug Active in NSCLC

(MedPage Today) -- Tumors with at least 50% PD-L1 expression associated with unexpected improvement. via MedPageToday.com - medical news plus CME for physicians Read More Here..
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)